Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Therapeutic use.

Artykuły w czasopismach na temat „Therapeutic use”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Therapeutic use”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Alvarez, Vincent, Jong Woo Lee, Frank W. Drislane, et al. "Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison." Epilepsia 56, no. 8 (2015): 1275–85. https://doi.org/10.1111/epi.13056.

Pełny tekst źródła
Streszczenie:
OBJECTIVE: Benzodiazepines (BZD) are recommended as first-line treatment for status epilepticus (SE), with lorazepam (LZP) and midazolam (MDZ) being the most widely used drugs and part of current treatment guidelines. Clonazepam (CLZ) is also utilized in many countries; however, there is no systematic comparison of these agents for treatment of SE to date. METHODS: We identified all patients treated with CLZ, LZP, or MDZ as a first-line agent from a prospectively collected observational cohort of adult patients treated for SE in four tertiary care centers. Relative efficacies of CLZ, LZP, and
Style APA, Harvard, Vancouver, ISO itp.
2

Varsha*, Robin George Shashank D. "Saroglitazar's Therapeutic Use in Metabolic Syndrome and Nafld." International Journal of Pharmaceutical Sciences 3, no. 3 (2025): 3200–3207. https://doi.org/10.5281/zenodo.15111106.

Pełny tekst źródła
Streszczenie:
Background: Saroglitazar is a novel anti-diabetic drug with combined PPAR-α/-γ agonistic activity. It was developed domestically by an Indian company called Zydus Cadila in 2001, and after numerous preclinical and clinical trials, it received regulatory approval from the Indian drug controller and regulatory authority called DCGI, India in June 2013. Non-alcoholic Fatty Liver Disease, diabetes, obesity, dyslipidemia, and cardiovascular disease are all grouped together as metabolic syndrome, and these conditions are caused by a sedentary and western lifestyle. Type 2 diabetes mellit
Style APA, Harvard, Vancouver, ISO itp.
3

Dvorak, J. "Therapeutic use exemption." British Journal of Sports Medicine 40, Supplement 1 (2006): i40—i42. http://dx.doi.org/10.1136/bjsm.2006.027490.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Nadler, S. F., M. A. Prybicien, D. Sicher, G. A. Malanga, M. DePrince, and J. E. Bowen. "THERAPEUTIC MODALITY USE." Medicine & Science in Sports & Exercise 33, no. 5 (2001): S90. http://dx.doi.org/10.1097/00005768-200105001-00519.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Neekhra, Sachin, Himani Awasthi, and DCP Singh. "Potential Therapeutic use of Streblus asper: A Review." International Journal of Research and Development in Pharmacy & Life Sciences 6, no. 7 (2017): 2845–49. http://dx.doi.org/10.21276/ijrdpl.2278-0238.2017.6(7).2845-2849.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Pradhan, Leena, Nicholas D. Andersen, Christoph Nabzdyk, Frank W. LoGerfo, and Aristidis Veves. "Wound-healing Abnormalities in Diabetes and New Therapeutic Interventions." US Endocrinology 00, no. 01 (2007): 68. http://dx.doi.org/10.17925/use.2007.00.1.68.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Alvarez, Vincent, Jean-Marie Januel, Bernard Burnand, and Andrea O. Rossetti. "Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam." Epilepsia 52, no. 7 (2011): 1292–96. https://doi.org/10.1111/j.1528-1167.2011.03056.x.

Pełny tekst źródła
Streszczenie:
PURPOSE: Phenytoin (PHT), valproic acid (VPA), or levetiracetam (LEV) are commonly used as second-line treatment of status epilepticus (SE), but comparative studies are not available. METHODS: Among 279 adult SE episodes identified prospectively in our tertiary care hospital over 4 years, we retrospectively identified 187 episodes in which PHT, VPA, or LEV were given after benzodiazepines. Patients with postanoxic SE were not included. Demographics, clinical SE features, failure of second-line treatment to control SE, new handicap, and mortality at hospital discharge were assessed. Uni- and mu
Style APA, Harvard, Vancouver, ISO itp.
8

Gallagher, Lisa M., and Francois Bethoux. "Therapeutic use of the Arts for Patients with Multiple Sclerosis." US Endocrinology 13, no. 02 (2017): 82. http://dx.doi.org/10.17925/use.2017.13.02.82.

Pełny tekst źródła
Streszczenie:
People with multiple sclerosis (MS) face a wide variety of physical, emotional, and social challenges. A multidisciplinary comprehensive care approach is recommended for the management of MS and its consequences, and non-traditional treatments are increasingly considered by patients and health care providers, particularly for the promotion of wellness in the context of this chronic disease. Previous research has demonstrated the benefits of the therapeutic arts (art therapy, dance and movement therapy, and music therapy) in addressing some of the physiological, psychological, cognitive, social
Style APA, Harvard, Vancouver, ISO itp.
9

Groeneweg, Stefan, Robin P. Peeters, Theo J. Visser, and W. Edward Visser. "Diagnostic and Therapeutic Challenges in the Allan—Herndon—Dudley Syndrome." US Endocrinology 12, no. 02 (2016): 90. http://dx.doi.org/10.17925/use.2016.12.02.90.

Pełny tekst źródła
Streszczenie:
Thyroid hormone (TH) is important for normal brain development. The TH transporter protein monocarboxylate transporter 8 (MCT8) is crucial to maintain adequate TH levels in the brain during development and throughout life. Mutations in MCT8 result in the Allan–Herndon–Dudley syndrome (AHDS), which is characterized by a severe delay in neurocognitive development, combined with abnormal serum thyroid function tests (TFTs). The combination of an increased (F)T3 and decreased (F)T4 and rT3 serum levels are characteristic for the presence of AHDS in male patients with moderate to severe delay in ne
Style APA, Harvard, Vancouver, ISO itp.
10

Kundu, Piyali, Taiyeba Tahira, and P. B Kar Mahapatra. "Multidimensional Therapeutic Use of 'Talisadichurna': An Ayurvedic Literary Review." International Journal of Science and Research (IJSR) 11, no. 6 (2022): 82–85. http://dx.doi.org/10.21275/sr22527162152.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
11

Tan, Robert S., Chris Ojeih, and Maurita Carrejo. "Potential Therapeutic Role of Androgens in Cognitive Loss Associated with Hypogonadism." US Endocrinology 00, no. 01 (2005): 1. http://dx.doi.org/10.17925/use.2005.00.01.1a.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Tan, Robert S., Chris Ojeih, and Maurita Carrejo. "Potential Therapeutic Role of Androgens in Cognitive Loss Associated with Hypogonadism." US Endocrinology 00, no. 01 (2005): 84. http://dx.doi.org/10.17925/use.2005.00.01.84.

Pełny tekst źródła
Streszczenie:
Memory problems late in life are common and are often easy to recognize. Hypogonadism in older men is not as readily identified, but it is also frequently a part of aging. Androgens, such as testosterone, have important hormonal influences on the brain and may prevent and possibly treat cognitive loss, including age-associated memory loss, mild cognitive impairment (MCI), and perhaps even Alzheimer’s disease (AD).There is support from small, prospective clinical trials that suggest the role of testosterone in improving cognitive function in normal men as well as hypogonadal men with AD. This i
Style APA, Harvard, Vancouver, ISO itp.
13

Rodriguez, Mariano, Juan Munoz-Castaneda, and Yolanda Almaden. "Therapeutic Use of Calcitriol." Current Vascular Pharmacology 12, no. 2 (2014): 294–99. http://dx.doi.org/10.2174/15701611113119990021.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Wall, Jenny, Sally Davis, and Samantha Ridgway. "Cannabis: its therapeutic use." Nursing Standard 16, no. 10 (2001): 39–44. http://dx.doi.org/10.7748/ns2001.11.16.10.39.c3123.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Hogaboam, Cory, Cynthia Bone-Larson, Akihiro Matsukawa, et al. "Therapeutic Use of Chemokines." Current Pharmaceutical Design 6, no. 6 (2000): 651–63. http://dx.doi.org/10.2174/1381612003400605.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Whall, Ann L. "THERAPEUTIC USE OF SELF." Journal of Gerontological Nursing 14, no. 2 (1988): 38–39. http://dx.doi.org/10.3928/0098-9134-19880201-09.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Jones, Janet. "Therapeutic use of metaphor." Nursing Standard 6, no. 11 (1991): 30–32. http://dx.doi.org/10.7748/ns.6.11.30.s34.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
18

Hebert, Steven C. "Therapeutic Use of Calcimimetics." Annual Review of Medicine 57, no. 1 (2006): 349–64. http://dx.doi.org/10.1146/annurev.med.57.121304.131328.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
19

&NA;, &NA;. "Therapeutic Use for Nicotine?" AJN, American Journal of Nursing 94, no. 6 (1994): 50. http://dx.doi.org/10.1097/00000446-199406000-00025.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Pridmore, Saxby. "Therapeutic use of rTMS." Nature Reviews Neuroscience 8, no. 10 (2007): 808. http://dx.doi.org/10.1038/nrn2169-c1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
21

Ridding, Michael C., and John C. Rothwell. "Therapeutic use of rTMS." Nature Reviews Neuroscience 8, no. 10 (2007): 808. http://dx.doi.org/10.1038/nrn2169-c2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
22

DE Gaudio, A. R. "Therapeutic Use of Albumin." International Journal of Artificial Organs 18, no. 4 (1995): 216–24. http://dx.doi.org/10.1177/039139889501800407.

Pełny tekst źródła
Streszczenie:
The clinical use of albumin solutions is a controversial issue, that involves albumin as a volume plasma expander, a supplement of total parenteral nutrition and a substance with pharmacological properties. The aim of this review is to show the present role of albumin in the clinical setting. We reviewed experimental and clinical data collected by the Medline System and the bibliographies of relevant articles. Experimental studies were selected on the basis of their historical value and applicability (hypothetical use, correct use) to the clinical setting. At present, it is possible to assert
Style APA, Harvard, Vancouver, ISO itp.
23

Soothill, James, Catherine Hawkins, Erik Änggår, and David Harper. "Therapeutic use of bacteriophages." Lancet Infectious Diseases 4, no. 9 (2004): 544–45. http://dx.doi.org/10.1016/s1473-3099(04)01127-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
24

Grotenhermen, Franjo. "Therapeutic use of cannabis." Lancet 351, no. 9104 (1998): 758–59. http://dx.doi.org/10.1016/s0140-6736(05)78538-x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
25

Winblad, Bengt, Mario Fioravanti, Tomas Dolezal, et al. "Therapeutic Use of Nicergoline." Clinical Drug Investigation 28, no. 9 (2008): 533–52. http://dx.doi.org/10.2165/00044011-200828090-00001.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

Stiehm, E. Richard, Jordan S. Orange, Mark Ballow, and Heather Lehman. "Therapeutic Use of Immunoglobulins." Advances in Pediatrics 57, no. 1 (2010): 185–218. http://dx.doi.org/10.1016/j.yapd.2010.08.005.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

Grotenhermen, Franjo. "Cannabinoids for Therapeutic Use." American Journal of Drug Delivery 2, no. 4 (2004): 229–40. http://dx.doi.org/10.2165/00137696-200402040-00003.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
28

Shore, Lisa B. "Therapeutic Use of Touch." Pediatric Physical Therapy 9, no. 1 (1997): 41. http://dx.doi.org/10.1097/00001577-199700910-00016.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
29

Goelitz, Ann, and Abigail Stewart Kahn. "Therapeutic Use of Space." Journal of Creativity in Mental Health 2, no. 4 (2008): 31–44. http://dx.doi.org/10.1300/j456v02n04_04.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

Balazs, Endre A. "Therapeutic use of hyaluronan." Structural Chemistry 20, no. 2 (2009): 341–49. http://dx.doi.org/10.1007/s11224-009-9435-y.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
31

Salvi, Mario, Guia Vannucchi, and Paolo Beck-Peccoz. "Rituximab for the Treatment of Graves’ Orbitopathy." US Endocrinology 07, no. 02 (2011): 130. http://dx.doi.org/10.17925/use.2011.07.02.130.

Pełny tekst źródła
Streszczenie:
The contribution of B-cells to human autoimmune disease has recently been underscored because of the therapeutic benefit of B-cell depleting therapies. B-cells are involved in the production of autoantibodies, and in CD4+ T-cell activation, control of T-cell function, and inflammation through cytokine production. B-cells are also important antigen-presenting cells. Rituximab (RTX) has been used off-label in various autoimmune disorders and has been shown to effectively deplete mature and memory CD20+ B-cells, but not long-lived plasma cells. The rationale behind the use of RTX in Graves’ disea
Style APA, Harvard, Vancouver, ISO itp.
32

Kranz, Florence. "Die Therapeutin als Werkzeug in der Beziehungsgestaltung – Therapeutic Use of Self." ergopraxis 18, no. 04 (2025): 34–37. https://doi.org/10.1055/a-2510-7600.

Pełny tekst źródła
Streszczenie:
Wenn wir mit Klient*innen arbeiten, hängt der Therapieerfolg nicht nur von fachlichen Kompetenzen und Konzepten ab. Entscheidend ist auch, wie wir die therapeutische Beziehung gestalten und uns selbst in den Kontakt einbringen. Der Artikel nimmt den Einsatz der eigenen Person und die Interaktion mit den Klient*innen unter die Lupe.
Style APA, Harvard, Vancouver, ISO itp.
33

Alam, Md Khorshed, Md Obydul Hoq, and Md Shahab Uddin. "Therapeutic use of Withania somnifera." Asian Journal of Medical and Biological Research 2, no. 2 (2016): 148–55. http://dx.doi.org/10.3329/ajmbr.v2i2.29004.

Pełny tekst źródła
Streszczenie:
Withania somnifera (L) Dunal is commonly called as Ashwagandha/Asgand and it belongs to the family Solanaceae. It is a well known medicinal plant widely used in the treatment of many clinical conditions in Indian subcontinent. It is an important medicinal plant commonly known as Asgand which has been used either single or in combination with other drugs in Unani as well as Ayurvedic system of medicine for centuries. It has been described by Dioscorides (78 AD) in his book “Kitab-ul-Hashaish”. Asgand consists of the roots of Withania somnifera which has various therapeutic actions such as anti
Style APA, Harvard, Vancouver, ISO itp.
34

Hossain, Md Tofazzal, and Md Obydul Hoq. "Therapeutic use of Adhatoda vasica." Asian Journal of Medical and Biological Research 2, no. 2 (2016): 156–63. http://dx.doi.org/10.3329/ajmbr.v2i2.29005.

Pełny tekst źródła
Streszczenie:
Adhatoda vasica Nees belonging to family Acanthaceae, commonly known as Adosa, is found many regions of India and throughout the world, with a multitude of uses in traditional Unani and Ayurvedic systems of medicine. It is also called “Vasaka”. It is a well-known herb in indigenous systems of medicine for its beneficial effects, particularly in bronchitis. Vasaka leaves, bark, the root bark, the fruit and flowers are useful in the removal of intestinal parasites. Vasaka herb is used for treating cold, cough, chronic bronchitis and asthma. In acute stages of bronchitis, vasaka gives unfailing r
Style APA, Harvard, Vancouver, ISO itp.
35

Nasser, Abdullah. "Ready-to-use therapeutic foods." University of Western Ontario Medical Journal 83, no. 2 (2014): 26–27. http://dx.doi.org/10.5206/uwomj.v83i2.4440.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

Medeiros, Aldo Cunha, and Vanessa De Fátima Lima de Paiva Medeiros. "Therapeutic use of coconut water." JOURNAL OF SURGICAL AND CLINICAL RESEARCH 3, no. 2 (2013): 83. http://dx.doi.org/10.20398/jscr.v3i2.3570.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

Poulton, James L., and Donald S. Strassberg. "The Therapeutic Use of Reminiscence." International Journal of Group Psychotherapy 36, no. 3 (1986): 381–98. http://dx.doi.org/10.1080/00207284.1986.11490910.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

Bell, Susan Givens. "The Therapeutic Use of Honey." Neonatal Network 26, no. 4 (2007): 247–51. http://dx.doi.org/10.1891/0730-0832.26.4.247.

Pełny tekst źródła
Streszczenie:
THE ANCIENTS WROTE OF THE healing properties of honey. A Sumerian tablet, possibly dated 3000 BCE, documents the treatment of an infected skin ulcer with honey. An Egyptian papyrus dated around 2000 BCE notes the use of honey to treat a gaping wound penetrating to the bone near the eyebrow. Aristotle (384–322 BCE) wrote about the use of honey to treat wounds and sore eyes. As with those of other natural substances, the healing benefits of honey were passed from generation to generation. Honey continues to be a popular medicine throughout the world, except in the U.S.1
Style APA, Harvard, Vancouver, ISO itp.
39

Salladay, Susan A. "Should Christians Use Therapeutic Touch?" Christian bioethics: Non-Ecumenical Studies in Medical Morality 8, no. 1 (2002): 25–42. http://dx.doi.org/10.1093/chbi.8.1.25.8756.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
40

Ehrenfeld, M., and R. Bergman. "The Therapeutic Use of Dolls." Perspectives in Psychiatric Care 31, no. 4 (2009): 21–22. http://dx.doi.org/10.1111/j.1744-6163.1995.tb00484.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
41

Bechler-Karsch, Abby. "The Therapeutic Use of Music." Worldviews on Evidence-Based Nursing E1, no. 1 (1994): 23–33. http://dx.doi.org/10.1111/j.1524-475x.1993.00023.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
42

Brock, Medina. "The Therapeutic Use of Clay." British Journal of Occupational Therapy 54, no. 1 (1991): 13–15. http://dx.doi.org/10.1177/030802269105400108.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
43

Krenning, Eric P., and Marion de Jong. "Therapeutic use of radiolabelled peptides." Annals of Oncology 11 (2000): 267–72. http://dx.doi.org/10.1093/annonc/11.suppl_3.267.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

Rode, Diane, Kathleen Leask Capitulo, Merri Fishman, and Gary Holden. "The Therapeutic Use of Technology." American Journal of Nursing 98, no. 12 (1998): 32–35. http://dx.doi.org/10.1097/00000446-199812000-00037.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
45

Rode, Diane, Kathleen Leask Capitulo, Merri Fishman, and Gary Holden. "The Therapeutic Use of Technology." AJN, American Journal of Nursing 98, no. 12 (1998): 32–35. http://dx.doi.org/10.1097/00000446-199898120-00021.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
46

Andrews, A. "Therapeutic use of bovine somatotrophin." Veterinary Record 132, no. 21 (1993): 540. http://dx.doi.org/10.1136/vr.132.21.540-a.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
47

Salladay, S. A. "Should Christians Use Therapeutic Touch?" Christian Bioethics 8, no. 1 (2002): 25–42. http://dx.doi.org/10.1076/chbi.8.1.25.8756.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
48

Little, John. "The therapeutic use of ‘no’." Australasian Psychiatry 23, no. 2 (2015): 136–38. http://dx.doi.org/10.1177/1039856214568225.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
49

Cohen, Susan M., Mary Ellen Rousseau, and Elizabeth H. Robinson. "Therapeutic Use of Selected Herbs." Holistic Nursing Practice 14, no. 3 (2000): 59–68. http://dx.doi.org/10.1097/00004650-200004000-00010.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
50

Cazenave, S. O. S., C. L. Correa, E. C. Freitas, and L. Matias. "Unsanctioned use of therapeutic drugs." Toxicology Letters 95 (July 1998): 122. http://dx.doi.org/10.1016/s0378-4274(98)80483-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!